ArticleCurrent neurovascular research2011

EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.

Zhao Zhong Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.